UPDATE: AMAG Pharma (AMAG) is Said to weigh Sale of Cord Blood Registry - Bloomberg

February 12, 2018 11:13 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - February 12, 2018 11:45 AM EST)

AMAG Pharma (NASDAQ: AMAG) is exploring options including a sale of its Cord Blood Registry business following interest from potential buyers, according to Bloomberg, citing people with knowledge of the matter. The unit has drawn both private equity firms and other drug makers.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk